All News

The CDC reveals current vaccination trends for COVID-19, flu, and RSV during the 2025-2026 respiratory virus season, highlighting public adoption rates.

This meta-analysis, which found no statistically significant OS differences by sex, age, or race with ICIs, highlights the need for more diverse, representative NSCLC trials.

Young adults with metastatic CRC (mCRC) and low socioeconomic status (SES) face higher 3-year mortality, whereas race was not independently linked with survival.

Patients with proinflammatory, pro-oxidative diets may face accelerated biological aging and increased skin cancer risk.

Allo-CAR-NK cell therapy shows promise in achieving long-term remission for patients with Waldenström lymphoma without chemotherapy.

Researchers unveil a spatial multi-omics atlas revealing immune cell interactions and lipid metabolism's role in metabolic liver diseases, offering new therapeutic insights.

New York City nurses continue their strike over staffing, safety, and benefits through negotiations on day 5 of the city’s largest nursing strike.

France approved botensilimab plus balstilimab for select ovarian cancers and soft tissue sarcomas, expanding early access to this dual immunotherapy.

As clinical trial activity accelerates and trial designs grow more complex, new data highlight persistent challenges with feasibility, enrollment, and early termination.

FDA granted breakthrough therapy designation to pemvidutide based on its potential in treating metabolic dysfunction–associated steatohepatitis (MASH).

Jose Guzman Garcia, PharmD, MHA, BCCCP, discusses key pharmacy initiatives at UC Davis Health.

With ACA subsidies in limbo, ICHRAs may reshape how Americans access coverage. Here are 5 FAQs explaining what they are, who benefits, and key trade-offs.

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

Alongside physician collaboration, patient advocacy is essential to ensure clinical trials and public policy reflect patient-centered outcomes.

Teclistamab was approved to treat relapsed/refractory multiple myeloma under the FDA’s accelerated approval pathway in October 2022.

Trump's Great Healthcare Plan aims to lower drug prices, reduce insurance premiums, and enhance transparency, according to the White House.

The Trump administration says it will restore vital SAMHSA funding after swift advocacy from mental health supporters.

Adults with hypertrophic cardiomyopathy living in lower-income or more socially deprived areas experienced significantly higher risks of heart failure, arrhythmias, stroke, and death.

A new analysis reveals effective therapies for reducing liver fat in metabolic dysfunction-associated steatohepatitis and highlights MRI-PDFF as a key measurement tool.

Black adolescents from lower-income households who engage in volunteer activities experience reduced odds of developing diabetes in adulthood.

Poland’s LiBRha project will expand liquid biopsy and molecular testing nationwide to improve diagnosis, monitoring, and outcomes for children with soft tissue sarcoma.

Based on these findings, the investigators encourage further research into this promising combination.

Patients with mantle cell lymphoma experienced better survival rates when treated at academic centers compared with community facilities.

Research reveals a potential link between preeclampsia and increased risks of chronic kidney disease, urging careful monitoring post pregnancy.

Federal grant terminations by SAMHSA threaten vital mental health and substance use services, risking lives amid rising suicide rates and addiction crises.

New research presented at ASCO GI positions both agents as potent therapeutic options, with potential to redefine standard care for aggressive HER2-driven gastrointestinal cancers.

The latest dietary guidelines emphasize reducing processed foods, promoting whole foods, and increasing protein intake, aiming to improve public health.

Adults with hypertension who have prediabetes and subclinical myocardial injury or stress face a higher risk of incident heart failure, a study suggests.